Cargando…
Omalizumab is effective in the preseasonal treatment of seasonal allergic rhinitis
BACKGROUND: To date no study has evaluated the efficacy of preseasonal omalizumab therapy with cost effective dose and at appropriate time point compared with standard medication in seasonal allergic rhinitis (SAR) patients. METHODS: This was a prospective randomized controlled open‐label single‐cen...
Autores principales: | Zhang, Yuan, Xi, Lin, Gao, Yunbo, Huang, Yanran, Cao, Feifei, Xiong, Wei, Wang, Chengshuo, Zhang, Luo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727318/ https://www.ncbi.nlm.nih.gov/pubmed/35024137 http://dx.doi.org/10.1002/clt2.12094 |
Ejemplares similares
-
Developing nomograms for identifying allergic rhinitis among chronic rhinitis: A real-world study
por: Huang, Yanran, et al.
Publicado: (2021) -
Comparative study of novel dosing schedules for interrupted immunotherapy for allergic rhinitis
por: Xi, Lin, et al.
Publicado: (2022) -
Clinical response to subcutaneous immunotherapy at 3 years in allergic rhinitis patients is predicted by short‐term treatment effectiveness
por: Liu, Dong, et al.
Publicado: (2023) -
Association between component-resolved diagnosis of house dust mite and efficacy of allergen immunotherapy in allergic rhinitis patients
por: Huang, Yanran, et al.
Publicado: (2019) -
Comparison of Long-term Efficacy of Subcutaneous Immunotherapy in Pediatric and Adult Patients With Allergic Rhinitis
por: Huang, Yanran, et al.
Publicado: (2018)